|1.||Corrêa, Rogério: 2 articles (09/2008 - 09/2004)|
|2.||de Moraes, Ana Carolina Rabello: 1 article (12/2013)|
|3.||Andrade, Evilásio da Silva: 1 article (12/2013)|
|4.||Bubniak, Lorena Dos Santos: 1 article (12/2013)|
|5.||de Oliveira, Kely Navakoski: 1 article (12/2013)|
|6.||Nunes, Ricardo José: 1 article (12/2013)|
|7.||Andreossi, Haíra Maria Slobodianuk: 1 article (12/2013)|
|8.||Santos-Silva, Maria Cláudia: 1 article (12/2013)|
|9.||Gaspar, Pâmela Cristina: 1 article (12/2013)|
|10.||Machado, Karina Elisa: 1 article (12/2013)|
01/01/1967 - "[Experimental studies with cyclic imides in dimethylbenzanthracene tumors of Sprague-Dawley rats]."
02/15/2008 - "Antiproliferative effects on human tumor cells and rat aortic smooth muscular cells of 2,3-heteroarylmaleimides and heterofused imides."
05/01/1997 - "The imides with methyl substituents (compounds 1 and 2) showed relatively higher selectivity against the tested cancer cell lines than the imides without methyl substituents (compounds 3 and 4). "
09/01/1985 - "Preliminary biological activity screening indicated that N-(dialkylaminoethyl)imides of the 3,6-dinitro- and 3,6-diamino-1,8-naphthalic acid system possessed prominent antileukemia and antimelanoma activity in both in vitro and in vivo experimental tumor systems."
02/01/1994 - "Cyclic imides such as N-substituted alkyl ethers, thioethers, sulfoxides, sulfones and related derivatives were potent agents against human single cell tumors and selected solid tumor growths, eg adenocarcinoma of the colon and glioma. "
12/16/2013 - "On the basis of this fact, we have developed a study starting from the synthesis of different cyclic imides and the evaluation of their cytotoxic properties on human acute leukemia cells (K562 and Jurkat). "
09/01/2008 - "Antiproliferative effects of a series of cyclic imides on primary endothelial cells and a leukemia cell line."
02/01/1987 - "In an attempt to discover a more potent compound, a number of bis-functionalized amides, imides, and hydrazine derivatives of HMBA were prepared and evaluated in vitro with the HL-60 human promyelocytic leukemia cell line. "
05/01/1998 - "A number of N-[(4-aryl)- or (4-methyl)-l-piperazinyl)alkyl]imides of 3-aryl or 3,3-pentamethylenesuccinic acid were synthesized and tested for anticonvulsant activity in the maximum electroshock seizure (MES) and pentylenetetrazole seizure threshold (scMet) tests. "
12/01/1998 - "In connection with the development of new anticonvulsant agents with a broad spectrum, we reported that N-Cbz-alpha-aminoglutarimides, combining common structures of other anticonvulsants such as N-CO-C-N and cyclic imides in a single molecule, showed significant anticonvulsant activities in the MES (maximal electroshock seizure) and PTZ (pentylenetetrazole induced seizure) tests. "
|4.||Melanoma (Melanoma, Malignant)
05/01/2003 - "The effect of imides, monothioimides, trimellitimides, as well as 5'-deoxy-5'-phthaloylamino-derivatives of azidothymidine on tumor necrosis factor-alpha (TNF-alpha) production by genetically modified murine B78H1 melanoma cells transduced with the gene for human TNF-alpha (B78/TNF) was investigated. "
09/01/2004 - "We now show the effects of several related cyclic imides: maleimides (S2, S2.1, S2.2, S3), glutarimides (S4, S5, S6), 4-aminoantipyrine derivatives (L1, F1, AL1, F1.14, F1.2) and sulfonated succinimides (RO1, FA, FE, FD, MC, DMC) on isolated rat liver mitochondria, B16-F10 melanoma cell line, peritoneal macrophages and different bacterial streams. "
|5.||Leprosy (Hansen's Disease)
|2.||Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)